semaglutide & tirzepatide manassas We are excited to announce that GLP-1 medications are back! Weekly Tirzepatide vs Semaglutide: Temecula Medical

Diet and Exercise : Focuses on creating a calorie deficit

95 % CI 4.5619.06), 15 % (RR 18.40

10.1038/s41398-019-0624-1 Trans

Byetta (immediate-release) : Half-life of 2.4 hours, requiring twice-daily subcutaneous injection 60 minutes before meals Bydureon (extended-release) : Exenatide encapsulated in biodegradable poly(D,L-lactide-co-glycolide) microspheres that release the peptide over weeks, enabling once-weekly dosing with a half-life of approximately 2 weeks Semaglutide: Human GLP-1 Based# Semaglutide is a 31-amino acid peptide with 94% homology to native human GLP-1

www.proteinatlas.org

Blood 94:154b, 1999